News

Checkpoint Therapeutics Beats Investor Suit Over FDA Approval
Checkpoint Therapeutics Inc. defeated investor claims it concealed the likelihood US regulators would deny its skin cancer ...
Nasdaq8d
Fortress Biotech Launches Emrosi™ for Rosacea Treatment and Announces Checkpoint Therapeutics Acquisition by Sun Pharma
The company also reported a planned acquisition of its subsidiary Checkpoint Therapeutics by Sun Pharmaceutical ... Fortress’ robust pipeline — including multiple late-stage programs and ...
BioSpace4d
Deep Dive: Checkpoint Inhibitors at a Crossroads
A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures ...
Morningstar10d
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Please see full Prescribing Information. About Checkpoint Therapeutics Checkpoint Therapeutics, Inc. is a commercial-stage immunotherapy and targeted oncology company focused on the acquisition ...
Finanznachrichten10d
Checkpoint Therapeutics, Inc: Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
May 13, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for ...